Company: RCUS
Filing Date: 2025-12-18
Form Type: 8-K
Source: 0001724521-25-000122
Chunk: 2

Company: Arcus Biosciences, Inc.
Filing Date: 2025-12-18
Form: 8-K
Item: Item 2.03
Chunk 2
---
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth above in Item 1.01 of this Current Report on Form 8-K regarding the Company’s direct financial obligation under the First Amendment is incorporated into this Item 2.03 by reference.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               ARCUS BIOSCIENCES, INC.                                     
  Date: December 18, 2025      By:                          /s/ Terry Rosen, Ph. D.        
                                                            Terry Rosen, Ph. D.            
                                                            Chief Executive Officer